• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session

    8/12/22 12:54:13 PM ET
    $ACRX
    $AEY
    $AIRS
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Office Equipment/Supplies/Services
    Industrials
    Get the next $ACRX alert in real time by email

    Gainers

    • Twin Vee Powercats Co. (NASDAQ:VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
    • Unity Biotechnology, Inc. (NYSE:UBX) jumped 70% to $1.4492 after the company announced 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325, which showed a statistically significant and clinical meaningful improvement in mean BVCA.
    • ADDvantage Technologies Group, Inc. (NASDAQ:AEY) shares gained 47.5% to $2.08 after the company swung to a profit in the third quarter.
    • Quhuo Limited (NASDAQ:QH) gained 37% to $6.23.
    • AppTech Payments Corp. (NASDAQ:APCX) jumped 35% to $0.97. AppTech Payments posted Q2 sales of $123.00K.
    • Embark Technology, Inc. (NASDAQ:EMBK) gained 29% to $0.7471 after the company reported better-than-expected Q2 EPS results.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) rose 28% to $1.8150. Neptune Wellness Solutions is expected to report its Q1 financial results on Monday, August 15, 2022.
    • Altimmune, Inc. (NASDAQ:ALT) jumped 28% to $17.64. B. Riley Securities maintained Altimmune with a Buy and raised the price target from $21 to $26.
    • Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) jumped 27.5% to $10.49. Rani Therapeutics reported termination of public offering of Class A common stock.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) gained 25.5% to $11.15 after the company reported better-than-expected Q2 sales results. The company also declared a special cash dividend of $0.41 per share.
    • Everspin Technologies, Inc. (NASDAQ:MRAM) jumped 24.8% to $7.99 after the company reported better-than-expected Q2 sales results and EPS results were higher year over year.
    • Brilliant Earth Group, Inc. (NASDAQ:BRLT) rose 23.8% to $7.98 following strong Q2 results.
    • Larimar Therapeutics, Inc. (NASDAQ:LRMR) shares gained 23.7% to $2.45 after the company announced it received meeting minutes from the FDA following a recent Type C Meeting and plans to submit a complete response to the CTI-1601 clinical hold in Q3.
    • Conifer Holdings, Inc. (NASDAQ:CNFR) gained 23.6% to $1.86. Clarkston Ventures purchased 1.5 million shares of Conifer Holdings at ab average price $2 per share.
    • Payoneer Global Inc. (NASDAQ:PAYO) shares rose 23.1% to $6.99 after reporting upbeat Q2 results.
    • Vision Marine Technologies Inc. (NASDAQ:VMAR) rose 22.6% to $7.85.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) shares rose 22.4% to $1.7384. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange.
    • Liquidia Corporation (NASDAQ:LQDA) jumped 21.6% to $6.94. The company recently posted upbeat quarterly results.
    • 89bio, Inc. (NASDAQ:ETNB) gained 20.8% to $4.93. 89bio posted a Q2 loss of $1.23 per share.
    • Xponential Fitness, Inc. (NYSE:XPOF) jumped 20.6% to $19.65 following strong quarterly sales.
    • LegalZoom.com, Inc. (NASDAQ:LZ) gained 20.5% to $13.29 after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • Invitae Corporation (NYSE:NVTA) surged 20% to $5.42. Invitae recently reported better-than-expected Q2 EPS results.
    • ESS Tech, Inc. (NYSE:GWH) jumped 18.2% to $4.9403 after the company announced a strategic partnership with Energy Storage Industries Asia Pacific to distribute and manufacture iron flow batteries in Australia, New Zealand and Oceania. The company also reported better-than-expected Q2 EPS results.
    • Rocket Lab USA, Inc. (NASDAQ:RKLB) rose 17% to $6.87 after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above analyst estimates.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) shares gained 16.6% to $2.81 after the company reported a $65 million oversubscribed offering.
    • Erasca, Inc. (NASDAQ:ERAS) gained 16.5% to $9.86 after the company reported Q2 EPS results were up year over year.
    • Latham Group, Inc. (NASDAQ:SWIM) rose 15.7% to $7.36. The company, on Thursday, reported Q2 results.
    • AN2 Therapeutics, Inc. (NASDAQ:ANTX) jumped 15.5% to $13.60. AN2 Therapeutics posted a Q2 loss of $0.53 per share.
    • Piedmont Lithium Inc. (NYSE:PLL) gained 15.3% to $64.61.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) jumped 14% to $9.05.
    • Berkshire Grey, Inc. (NASDAQ:BGRY) rose 13.8% to $2.4811.
    • RAPT Therapeutics, Inc. (NASDAQ:RAPT) gained 13.7% to $27.72. HC Wainwright & Co. maintained RAPT Therapeutics with a Buy and raised the price target from $50 to $53.
    • Toast, Inc. (NYSE:TOST) shares rose 13.6% to $20.62 after the company reported better-than-expected Q2 sales and raised FY22 guidance.
    • Vuzix Corporation (NASDAQ:VUZI) gained 13.5% to $10.37 after the company announced it received a six-figure order from a global Tier-1 aerospace and defense firm for additional pre-production units of its customized avionics waveguide-based head mounted display system.
    • Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) gained 13% to $27.63. Day One Biopharmaceutical recently posted a Q2 loss of $0.60 per share.
    • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) gained 12.9% to $0.9240.
    • GoHealth, Inc. (NASDAQ:GOCO) gained 12.7% to $0.7150.
    • Oscar Health, Inc. (NYSE:OSCR) rose 12.2% to $7.32 after the company reported better-than-expected Q2 sales results.
    • EVgo, Inc. (NASDAQ:EVGO) gained 10.8% to $11.37.
    • Lordstown Motors Corp. (NASDAQ:RIDE) gained 9.9% to $2.8801.
    • Offerpad Solutions Inc. (NASDAQ:OPAD) rose 9.5% to $1.85. Offerpad Solutions Director Roberto Sella acquired a total of 1,000,000 shares at an average price of $1.69.
    • DraftKings Inc. (NASDAQ:DKNG) gained 9.5% to $20.33 after a Massachusetts sports betting bill was recently signed into law.
    • Joby Aviation, Inc. (NYSE:JOBY) rose 5% to $6.46 after the company posted a narrower-than-expected quarterly loss.


    Losers

    • Treasure Global Inc. (NASDAQ:TGL) fell 58.3% to $7.43 Treasure Global shares jumped around 345% on Thursday after the company priced its IPO at $4 per share.
    • CS Disco, Inc. (NYSE:LAW) shares tumbled 52.9% to $13.65 after the company reported Q2 earnings and issued weak Q3 guidance.
    • Performance Shipping Inc. (NASDAQ:PSHG) fell 49.4% to $0.3120 after the company priced its 33 million share offering at $0.45 per share.
    • PLx Pharma Inc. (NASDAQ:PLXP) fell 38.9% to $1.5816. PLx Pharma posted a Q2 loss of $0.52 per share.
    • Olo Inc. (NYSE:OLO) shares fell 33.2% to $8.68 after the company reported Q2 results and issued FY22 guidance below consensus estimates.
    • SmartRent, Inc. (NASDAQ:SMRT) dipped 32.7% to $3.7750 after the company reported worse-than-expected Q2 results and issued FY22 sales guidance below estimates.
    • IMAC Holdings, Inc. (NASDAQ:BACK) fell 32.7% to $0.6361 after the company announced a registered direct offering of roughly 5.1 million shares priced at $0.76 per share.
    • Aptinyx Inc. (NASDAQ:APTX) dipped 32.5% to $0.4049 after the company announced results from its Phase 2b Study of NYX-2925 did not achieve the primary endpoint.
    • Co-Diagnostics, Inc. (NASDAQ:CODX) shares fell 29.2% to $4.5750 after the company reported downbeat results for its second quarter on Thursday.
    • Palisade Bio, Inc. (NASDAQ:PALI) fell 28.9% to $0.2381 after the company reported pricing of $12 million upsized underwritten public offering.
    • Usio, Inc. (NASDAQ:USIO) dropped 28% to $1.67 after the company posted a loss for its second quarter.
    • Dave Inc. (NASDAQ:DAVE) fell 24.8% to $0.6456 after the company posted downbeat quarterly sales.
    • Sientra, Inc. (NASDAQ:SIEN) dropped 24.4% to $0.9218 after the company posted a Q2 loss and lowered FY22 revenue guidance.
    • Innodata Inc. (NASDAQ:INOD) declined 24.4% to $4.97 after the company reported Q2 earnings results.
    • Rekor Systems, Inc. (NASDAQ:REKR) dipped 23% to $1.60 after the company reported Q2 earnings results.
    • Smith Micro Software, Inc. (NASDAQ:SMSI) fell 21.7% to $2.3750 after the company reported Q2 EPS results were down year over year.
    • Magic Empire Global Limited (NASDAQ:MEGL) dropped 21% to $8.61.
    • Apyx Medical Corporation (NASDAQ:APYX) declined 20.2% to $8.20 after the company reported worse-than-expected Q2 sales results.
    • Nocera, Inc. (NASDAQ:NCRA) fell 18.4% to $2.2095. Nocera, on Thursday. announced pricing of $6.58 million public offering, Nasdaq listing and reverse stock split.
    • 1847 Holdings LLC (NASDAQ:EFSH) fell 17% to $3.18 following Q2 results.
    • TOP Financial Group Limited (NASDAQ:TOP) fell 16.4% to $16.07 after jumping 52% on Thursday.
    • Applied DNA Sciences, Inc. (NASDAQ:APDN) dropped 16.1% to $3.79 following Q3 results.
    • ForgeRock, Inc. (NYSE:FORG) declined 15.6% to $18.76 after the company issued Q3 adjusted EPS and sales guidance below estimates.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) fell 15.2% to $12.02 after the company reported wider quarterly loss.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) dropped 15% to $1.93 after the company reported its Q2 financial results. Additionally, multiple firms lowered their price target on the stock.
    • PolarityTE, Inc (NASDAQ:PTE) fell 14.8% to $1.38 after reporting downbeat quarterly earnings.
    • Digital Media Solutions, Inc. (NYSE:DMS) fell 14.7% to $1.80 after jumping around 79% on Thursday. The company reported its Q2 earnings Tuesday.
    • Certara, Inc. (NASDAQ:CERT) dipped 14.4% to $17.29 after the company announced a secondary offering of 7 million shares of common stock.
    • AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) shares fell 13.5% to $0.2700 after the company reported Q2 results.
    • Natura &Co Holding S.A. (NYSE:NTCO) dipped 12.4% to $5.41 as the company reported a wider-than-expected quarterly loss.
    • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) declined 12.4% to $9.10 after the company reported Q2 EPS results were down year over year. Additionally, SVB Leerink downgraded the stock from Outperform to Market Perform and lowered its price target from $28 to $12.
    • Poshmark, Inc. (NASDAQ:POSH) dropped 12% to $11.33 after the company reported worse-than-expected Q2 EPS results and issued Q3 sales guidance below estimates.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 11.7% to $0.5299. Esports Entertainment Group shares jumped 32% on Thursday after Massachusetts Governor Baker on Wednesday signed a sports betting bill into law.
    • Expensify, Inc. (NASDAQ:EXFY) fell 11.4% to $21.49 following weak Q2 sales.
    • Zealand Pharma A/S (NASDAQ:ZEAL) dropped 11% to $15.55. Zealand Pharma, on Thursday, announced preliminary H2 2022 revenue of $6.1 million.
    • NextNav Inc. (NASDAQ:NN) fell 10.9% to $3.02 after Oppenheimer downgraded the stock from Outperform to Perform.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) dipped 10% to $7.43.
    • Snap One Holdings Corp. (NASDAQ:SNPO) fell 10% to $11.25 after reporting a Q2 loss.
    • Illumina, Inc. (NASDAQ:ILMN) fell 9.3% to $206.25 after the company reported worse-than-expected results for its second quarter and issued weak full-year 2022 guidance.
    • The RealReal, Inc. (NASDAQ:REAL) dropped 7.7% to $2.9150 after Cowen & Co. downgraded the stock from Outperform to Market Perform and lowered its price target from $14 to $3.
    • Wag! Group Co. (NASDAQ:PET) fell 7.2% to $7.61.
    Get the next $ACRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRX
    $AEY
    $AIRS
    $ALT

    CompanyDatePrice TargetRatingAnalyst
    Apyx Medical Corporation
    $APYX
    3/11/2026$6.00Neutral → Buy
    BTIG Research
    Day One Biopharmaceuticals Inc.
    $DAWN
    3/10/2026$21.50Buy → Neutral
    H.C. Wainwright
    Pacific Biosciences of California Inc.
    $PACB
    3/6/2026$1.50Equal Weight → Underweight
    Barclays
    Certara Inc.
    $CERT
    3/6/2026$8.00Overweight → Equal Weight
    Barclays
    Brilliant Earth Group Inc.
    $BRLT
    3/6/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Brilliant Earth Group Inc.
    $BRLT
    3/6/2026$1.50Buy → Neutral
    B. Riley Securities
    LegalZoom.com Inc.
    $LZ
    3/4/2026$6.00Equal Weight → Underweight
    Barclays
    Xponential Fitness Inc.
    $XPOF
    2/27/2026$7.00Buy → Neutral
    Roth Capital
    More analyst ratings

    $ACRX
    $AEY
    $AIRS
    $ALT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chernett Jorey bought $91,200 worth of shares (45,600 units at $2.00), increasing direct ownership by 0.72% to 6,398,211 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    3/9/26 8:40:24 AM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:00:05 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AEY
    $AIRS
    $ALT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 30, 2024 - FDA Roundup: April 30, 2024

    For Immediate Release: April 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/30/24 3:20:20 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    April 26, 2024 - FDA Roundup: April 26, 2024

    For Immediate Release: April 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/26/24 3:10:22 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OJEMDA issued to DAY ONE BIOPHARMACEUTICALS INC

    Submission status for DAY ONE BIOPHARMACEUTICALS INC's drug OJEMDA (ORIG-1) with active ingredient TOVORAFENIB has changed to 'Approval' on 04/23/2024. Application Category: NDA, Application Number: 218033, Application Classification: Type 1 - New Molecular Entity

    4/24/24 12:52:43 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AEY
    $AIRS
    $ALT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Apyx Medical upgraded by BTIG Research with a new price target

    BTIG Research upgraded Apyx Medical from Neutral to Buy and set a new price target of $6.00

    3/11/26 8:28:33 AM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Day One Biopharmaceuticals downgraded by H.C. Wainwright with a new price target

    H.C. Wainwright downgraded Day One Biopharmaceuticals from Buy to Neutral and set a new price target of $21.50

    3/10/26 8:39:03 AM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pacific Biosciences downgraded by Barclays with a new price target

    Barclays downgraded Pacific Biosciences from Equal Weight to Underweight and set a new price target of $1.50

    3/6/26 8:26:02 AM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ACRX
    $AEY
    $AIRS
    $ALT
    SEC Filings

    View All

    SEC Form 144 filed by DraftKings Inc.

    144 - DraftKings Inc. (0001883685) (Subject)

    3/11/26 4:07:05 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Joby Aviation Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Joby Aviation, Inc. (0001819848) (Filer)

    3/11/26 4:16:47 PM ET
    $JOBY
    Aerospace
    Industrials

    SEC Form 424B3 filed by Offerpad Solutions Inc.

    424B3 - Offerpad Solutions Inc. (0001825024) (Filer)

    3/11/26 4:05:15 PM ET
    $OPAD
    Real Estate
    Finance

    $ACRX
    $AEY
    $AIRS
    $ALT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Liquidia Corporation

    4 - Liquidia Corp (0001819576) (Issuer)

    3/11/26 4:30:32 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner National Services, Inc sold $24,343 worth of shares (18,860 units at $1.29), decreasing direct ownership by 0.69% to 2,721,272 units (SEC Form 4)

    4 - Usio, Inc. (0001088034) (Issuer)

    3/11/26 4:01:28 PM ET
    $USIO
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by LegalZoom.com Inc.

    4 - LEGALZOOM.COM, INC. (0001286139) (Issuer)

    3/10/26 6:01:23 PM ET
    $LZ
    EDP Services
    Technology

    $ACRX
    $AEY
    $AIRS
    $ALT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NextNav to Participate in the 38th Annual Roth Conference

    NextNav Inc. (NASDAQ:NN), a leader in next-generation terrestrial Positioning, Navigation, and Timing (PNT) and 3D geolocation solutions, today announced that Chief Financial Officer, Tim Gray, will participate in the Roth 38th Annual Conference, held in Laguna Niguel, CA on March 23rd-24th, 2026. To schedule a meeting with NextNav, please reach out to your Roth representative. About NextNav NextNav Inc. (NASDAQ:NN) is a leader in next-generation 3D Positioning, Navigation, and Timing (PNT) solutions. As the nation's largest license holder in a spectrum band expressly designated for terrestrial positioning services, NextNav is uniquely positioned to enable a widescale terrestrial comp

    3/11/26 4:31:00 PM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Vision Marine Technologies Positions for Scalable Electric Adoption Through Dominant Pontoon Segment; Introduces SPECTR 26 Flagship Platform

    Corporate Updates and StrategyMONTREAL, March 11, 2026 /PRNewswire/ -- Vision Marine Technologies Inc. (NASDAQ:VMAR) ("Vision Marine" or the "Company"), a company specializing in electric marine propulsion and multi brand boat retail operations, today detailed its strategic focus on the North American pontoon segment, one of the most commercially significant categories in recreational boating. According to industry reporting based on data published by the National Marine Manufacturers Association, pontoon boats are estimated to have achieved 52,000 to 55,000 new unit sales in th

    3/11/26 11:54:00 AM ET
    $VMAR
    Marine Transportation
    Industrials

    How Americans are Changing Their Coffee Drinking Habits

    Toast (NYSE:TOST) released its latest Restaurant Trends Report, providing insight into the state of the U.S. restaurant industry through an analysis of aggregated data from selected cohorts of restaurants and in select U.S. states on the Toast platform, which serves approximately 164,000 locations as of December 31, 2025. Read the full Restaurant Trends Report on Data by Toast. Key takeaways from the report: Premium growth: Sales for barista-crafted drinks increased in 2025 compared to 2024, including lattes (+4.0%), espresso shots (+3.3%), and Americanos (+1.4%).1 Staple declines: Traditional beverages pulled back, with regular hot drip coffee sales down 3.3% and cold brew down 2.2

    3/11/26 8:00:00 AM ET
    $TOST
    EDP Services
    Technology

    $ACRX
    $AEY
    $AIRS
    $ALT
    Leadership Updates

    Live Leadership Updates

    View All

    Payoneer and FundPark Collaborate to Expand Dynamic, Frictionless Credit Access for Global E-Commerce Sellers

    NEW YORK, March 10, 2026 /PRNewswire/ -- Payoneer Global Inc. ("Payoneer" or the "Company") (NASDAQ:PAYO), the global financial technology company powering business growth across borders, today announced a strategic collaboration with FundPark, a fintech scale-up committed to empowering fast-growing digital entrepreneurs, to broaden access to financing solutions for eligible e-commerce businesses incorporated in Hong Kong and help accelerate their global business expansion. Through this collaboration, FundPark will provide its AI‑driven digital financing solutions to eligible Payoneer customers. 

    3/10/26 8:00:00 PM ET
    $PAYO
    Real Estate

    The RealReal Announces Board of Directors and Executive Leadership Updates

    SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- The RealReal, Inc. (NASDAQ:REAL), the world's largest online marketplace for authenticated luxury resale, today announced changes to its Board of Directors and executive leadership team, further strengthening the Company's governance and operational leadership as it advances its next phase of growth. Board of Directors Update The RealReal announced the appointment of Jennifer McKeehan to its Board of Directors and the departure of Niki Leondakis from her role as a Board member, both effective March 6, 2026. McKeehan currently serves as Chief Operating Officer of Fanatics Commerce at Fanatics, Inc., and brings extensive experience leading

    3/9/26 4:05:00 PM ET
    $REAL
    Other Specialty Stores
    Consumer Discretionary

    PacBio Announces the Appointment of Chris Gibson to the Board of Directors

    MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio's Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of Directors of Recursion (NASDAQ:RXRX), a clinical-stage biotechnology company that has built one of the industry's most advanced AI-driven drug discovery platforms. Under his leadership, Recursion integrated large-scale biological data generation with machine learning to industrialize the discovery process, building a vertically integrated technology stack spanning automation, high-dimensional b

    3/5/26 8:30:00 AM ET
    $PACB
    $RXRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACRX
    $AEY
    $AIRS
    $ALT
    Financials

    Live finance-specific insights

    View All

    Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

    Reported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System™ (AYON) to meet strong market demandExpect FY2026 total revenue in the range of $57.5 million to $58.5 millionManagement to host a conference call today at 8:00 a.m. ET CLEARWATER, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its fourth quarter and full year ended December 31, 2025. Recent Financial and Operating Highlights: Reported

    3/10/26 7:00:00 AM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity

    Company announcement – No. 3 / 2026 Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity Petrelintide achieved up to 10.7% mean body weight reduction at week 42 (versus 1.7% with placebo) and demonstrated placebo-like tolerabilityAt the maximally effective dose, there were no cases of vomiting and no treatment discontinuations due to gastrointestinal adverse eventsThe data reinforce further development of petrelintide in chronic weight management as monotherapy and as a combination partnerZealand Pharma will host a conference call today at 8:30 PM CET /

    3/5/26 1:45:00 PM ET
    $ZEAL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Brilliant Earth Reports Record Quarterly Net Sales

    Delivered 4% Y/Y Net Sales Growth Drove 34% Y/Y Bookings Growth in Fine JewelryProvides Q1 and Full Year Guidance 2026 SAN FRANCISCO, March 05, 2026 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. ("Brilliant Earth" or the "Company") (NASDAQ:BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced financial results for the three and twelve months ended December 31, 2025. Fourth Quarter and Fiscal Year 2025 Highlights (quarterly and annual periods ended December 31, 2025): Delivered Net Sales of $124.4 million and $437.5 million in the fourth quarter and fiscal year, respectively. Largest quarter ever of Net SalesTotal orders grew year-over-year 7% in Q4 and

    3/5/26 6:45:00 AM ET
    $BRLT
    Consumer Specialties
    Consumer Discretionary

    $ACRX
    $AEY
    $AIRS
    $ALT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NextNav Inc.

    SC 13D/A - NEXTNAV INC. (0001865631) (Subject)

    12/6/24 6:03:25 PM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials